Hypertension/High Blood Pressure
Show Only Open Trials
1.
Relationship of Plasma Renin Activity to Response of Microalbuminuria to Angiotensin Converting Enzyme Inhibition
- Study Status: Open to Enrollment
- Sponsor: Hypertension Research Fund
2.
Treatment algorithm for resistant hypertension
- Study Status: Open to Enrollment
- Sponsor: Hypertension Research Fund
3.
Heart Failure and Pulmonary Hypertension Registry
- Study Status: Open to Enrollment
4.
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of Cicletanine in Subjects with Pulmonary Arterial Hypertension
- Study Status: Open to Enrollment
- Sponsor: Gilead Sciences
5.
The Natural History and Outcome of Scleroderma Patients at High Risk or with Early Pulmonary Hypertension
- Study Status: Open to Enrollment
- Sponsor: Georgetown University
6.
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
- Study Status: Open to Enrollment
- Sponsor: NIH/NIMHD
7.
ATHENA-1: An Open-Label, Multicenter Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor Combination Therapy in Subjects with Pulmonary Arterial Hypertension Who Have Demonstrated a Suboptimal Response to Phosphodiesterase Type-5 Inhibitor
- Study Status: Closed to Enrollment
- Sponsor: Gilead Sciences
8.
Cytokine Levels in Hypertensive and Normotensive Individuals
- Study Status: Closed to Enrollment
9.
Rapid Switch from Intravenous Epoprostenol to Intravenous Remodulin (Treprostinil Sodium) Using the Crono Five Ambulatory Infusion Pump in Patients with Stable Pulmonary Arterial Hypertension: Safety, Efficacy and Treatment Satisfaction
- Study Status: Open to Enrollment
- Sponsor: United Therapeutics
